Nevertheless, the availability of C5 genome-wide association studies (GWAS) and the periodontitis GWAS created the opportunity to study the potential therapeutic impact of the genetically proxied inhibition of C5 using cis-IVs on periodontitis risk. Here, C5 is linked to periodontitis.